In 2025, the Russian electronic pharmaceutical market may surge past a value of 460 billion rubles.
In the rapidly evolving landscape of the pharmaceutical industry, Russia's ePharma market has witnessed significant growth in 2025. According to recent data, the market is expected to reach a staggering volume of 460 billion rubles by the end of the year, marking a 20-22% increase from 2024.
One of the key drivers of this growth is the surge in online pharmacy sales. In June 2025 alone, Russian online pharmacies fulfilled 21.4 million orders, a 24% increase from June 2024. This trend is reflected in the market's overall performance, with online orders accounting for approximately 22% of the total volume in 2025.
Apteka.ru (AO "Nauchnо-Proizvodstvennaya Kompaniya "Kratren") emerged as the largest player in terms of sales in 2024, holding a share of 21.1% of orders and 22.2% of the market in terms of revenue. Close competitors include "Yuteka" and "ZdravCity", which accounted for approximately 15% and 10% of the market, respectively, making these three brands responsible for approximately 41% of all online orders each month. April network leads the ranking of the largest pharmaceutical retailers in Russia.
The rise of online pharmacies has also seen an increase in the frequency of purchases. A survey revealed that 23% of respondents noted an increase in the frequency of their purchases online, while nearly 15% of buyers this year started ordering over-the-counter medications online.
Interestingly, the ePharma market's growth is not limited to traditional pharmaceutical products. Sales of anxiety and stress-fighting tablets have been growing for the third year in a row since 2022, with 9.3 million packages of tranquilizers and almost 11 million packages of antidepressants sold in the first six months of 2025. Initially intended to treat diabetes, ozempic analogs are now widely used for weight loss in Russia. In the first six months of 2025, 2.2 million packages of ozempic analogs were sold, with sales reaching 12.5 billion rubles.
The market's expansion is not only quantitative but also qualitative. Only five online pharmacies operated on universal marketplaces in 2024, but this number is expected to grow as more companies adopt this strategy. Ten companies used express delivery services in 2024, a number that is likely to increase as customers demand faster and more efficient delivery options.
Rigla, a prominent player in the market, further solidified its position by buying another pharmacy network and increasing the total number of pharmacies to almost 5,500.
Despite the market's promising outlook, the search results do not provide specific information about which company will have the largest sales volume in the ePharma market in 2025. However, with the ongoing trends and the continuous evolution of the market, it is clear that the ePharma industry in Russia is poised for continued growth and innovation.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
